Nitches, Inc. Drives Innovation With InTheZone Labs’ Groundbreaking Phase One Testing
Nitches, Inc. (OTC PINK:NICH) announces the commencement of Phase One Testing for its InTheZone Labs division's bioceutical products. The company is developing three flagship products: InTheZone Focused Extreme for mental clarity, InTheZone Passion for men's vitality, and InTheZone Youth for cognitive development in children and young adults.
The testing phase will involve three key groups: veterans and their families, medical and chiropractic experts, and former NFL players. This comprehensive approach aims to gather critical insights and refine the products for various demographics. Nitches encourages the public to visit InTheZoneLabs.com to explore and purchase these products.
The company is positioning itself to capitalize on the projected $650 billion nutraceutical and bioceutical market by 2027, offering American-made, science-backed health solutions.
Nitches, Inc. (OTC PINK:NICH) annuncia l'inizio della Fase Uno di Test per i prodotti bioceutici della sua divisione InTheZone Labs. L'azienda sta sviluppando tre prodotti di punta: InTheZone Focused Extreme per la chiarezza mentale, InTheZone Passion per la vitalità maschile e InTheZone Youth per lo sviluppo cognitivo nei bambini e nei giovani adulti.
La fase di test coinvolgerà tre gruppi chiave: veterani e le loro famiglie, esperti medici e chiropratici, e ex giocatori della NFL. Questo approccio completo mira a raccogliere informazioni cruciali e affinare i prodotti per diverse demografie. Nitches invita il pubblico a visitare InTheZoneLabs.com per esplorare e acquistare questi prodotti.
L'azienda si sta posizionando per capitalizzare sul mercato nutraceutico e bioceutico previsto di 650 miliardi di dollari entro il 2027, offrendo soluzioni sanitarie americane supportate dalla scienza.
Nitches, Inc. (OTC PINK:NICH) anuncia el inicio de la Fase Uno de Pruebas para los productos bioceuticos de su división InTheZone Labs. La empresa está desarrollando tres productos insignia: InTheZone Focused Extreme para la claridad mental, InTheZone Passion para la vitalidad masculina, y InTheZone Youth para el desarrollo cognitivo en niños y jóvenes adultos.
La fase de pruebas involucrará tres grupos clave: veteranos y sus familias, expertos médicos y quiroprácticos, y exjugadores de la NFL. Este enfoque integral tiene como objetivo recopilar información crítica y refinar los productos para varias demografías. Nitches anima al público a visitar InTheZoneLabs.com para explorar y adquirir estos productos.
La empresa se está posicionando para capitalizar en el mercado nutracéutico y bioceutico proyectado de 650 mil millones de dólares para 2027, ofreciendo soluciones de salud de fabricación estadounidense respaldadas por la ciencia.
Nitches, Inc. (OTC PINK:NICH)는 InTheZone Labs 부문의 생물 의약품 제품에 대한 1단계 시험 시작을 발표했습니다. 이 회사는 정신적 명료성을 위한 InTheZone Focused Extreme, 남성의 활력을 위한 InTheZone Passion, 아동 및 청소년의 인지 발달을 위한 InTheZone Youth라는 세 가지 주력 제품을 개발하고 있습니다.
시험 단계에는 세 가지 주요 그룹이 포함됩니다: 재향군인 및 그 가족, 의료 및 카이로프랙틱 전문가, 그리고 전 NFL 선수들. 이 포괄적인 접근법은 중요한 통찰력을 수집하고 다양한 인구 통계에 맞춰 제품을 개선하는 것을 목표로 하고 있습니다. Nitches는 대중이 InTheZoneLabs.com을 방문하여 이 제품들을 탐색하고 구매할 것을 권장합니다.
회사는 2027년까지 6,500억 달러에 이를 것으로 예상되는 영양소 및 생물 의약품 시장을 활용하기 위해 자리 잡고 있으며, 과학적으로 뒷받침된 미국산 건강 솔루션을 제공합니다.
Nitches, Inc. (OTC PINK:NICH) annonce le début des tests de la phase un pour ses produits bioceutiques de la division InTheZone Labs. L'entreprise développe trois produits phares : InTheZone Focused Extreme pour la clarté mentale, InTheZone Passion pour la vitalité masculine, et InTheZone Youth pour le développement cognitif chez les enfants et les jeunes adultes.
La phase de test impliquera trois groupes clés : des vétérans et leurs familles, des experts médicaux et chiropratiques, ainsi que d'anciens joueurs de la NFL. Cette approche globale vise à recueillir des informations critiques et à affiner les produits pour différentes démographies. Nitches encourage le public à visiter InTheZoneLabs.com pour explorer et acheter ces produits.
L'entreprise se positionne pour capitaliser sur le marché nutraceutique et bioceutique projeté à 650 milliards de dollars d'ici 2027, offrant des solutions de santé fabriquées aux États-Unis et soutenues par la science.
Nitches, Inc. (OTC PINK:NICH) gibt den Beginn der Phase Eins der Tests für die bioceutischen Produkte seiner Abteilung InTheZone Labs bekannt. Das Unternehmen entwickelt drei Hauptprodukte: InTheZone Focused Extreme für mentale Klarheit, InTheZone Passion für die Vitalität von Männern und InTheZone Youth für die kognitive Entwicklung bei Kindern und jungen Erwachsenen.
Die Testphase wird drei Schlüsselgruppen umfassen: Veteranen und ihre Familien, medizinische und chiropraktische Experten sowie ehemalige NFL-Spieler. Dieser umfassende Ansatz zielt darauf ab, wichtige Erkenntnisse zu sammeln und die Produkte für verschiedene Demografien zu verfeinern. Nitches ermutigt die Öffentlichkeit, InTheZoneLabs.com zu besuchen, um diese Produkte zu erkunden und zu kaufen.
Das Unternehmen positioniert sich, um vom projizierten Markt für Nutraceuticals und Bioceuticals im Wert von 650 Milliarden Dollar bis 2027 zu profitieren, und bietet wissenschaftlich fundierte Gesundheitslösungen, die in Amerika hergestellt werden.
- Launch of Phase One Testing for InTheZone Labs' bioceutical products
- Development of three flagship products targeting mental clarity, men's vitality, and cognitive development
- Involvement of diverse test groups including veterans, medical experts, and former NFL players
- Products now available for purchase on InTheZoneLabs.com
- Positioning to capitalize on the projected $650 billion nutraceutical and bioceutical market by 2027
- None.
LAS VEGAS, NV / ACCESSWIRE / October 21, 2024 / Nitches, Inc. (OTC PINK:NICH) is excited to announce the next big step in the evolution of its InTheZone Labs division. As we prepare for Phase One Testing of our game-changing bioceutical products, we are inviting everyone to visit InTheZoneLabs.com to learn more about how these cutting-edge formulas can help unlock focus, vitality, and cognitive enhancement for users across a wide range of needs.
InTheZone Labs is not just a supplement line-it's a movement toward better health, sharper focus, and elevated performance. We've spent months developing precision formulations that address common challenges from mental fog and physical fatigue to cognitive underperformance and reproductive health. Our primary focus has been on the three flagship products that are already gaining attention:
InTheZone Focused Extreme: A potent formula designed to enhance mental clarity, memory, and focus for individuals who need to perform at their peak-be it in the office, the classroom, or in their everyday lives.
InTheZone Passion: Crafted specifically to support men's vitality, libido, and reproductive health, Passion helps address the global decline in sperm health and testosterone, offering a natural solution to enhance energy and virility.
InTheZone Youth: Designed to support cognitive development and focus in children and young adults, Youth is formulated with brain-enhancing ingredients that fuel learning and mental performance.
Announcing Phase One Testing: Comprehensive Feedback from Key Groups
InTheZone Labs is now gearing up for Phase One Testing to gather critical insights from real-world users across three key groups. We are dedicated to perfecting our products, and this phase is an essential step in gathering feedback that will help shape the future of InTheZone Labs:
1. Veterans and Their Families
We are proud to announce that veterans from various branches of service will be part of this groundbreaking study. Our focus will be on the effects of InTheZone Focused and InTheZone Passion in enhancing cognitive performance, mental clarity, and vitality among veterans. Additionally, we will be extending testing of InTheZone Youth to the children of veterans to evaluate its impact on focus and cognitive development in younger age groups. Their feedback will help refine our products for these unique and vital demographics.
2. Medical and Chiropractic Expertise
Two key leaders will be heading separate verticals in our testing process-a Medical Doctor (to be named later) and a Doctor of Chiropractic (to be named later). These prominent figures, each leaders in their respective fields, will help test our products within their networks, gathering insights from individuals in medical and holistic healthcare. Their evaluations will give us a deeper understanding of how our supplements perform across different health contexts, ensuring our formulas continue to meet the highest standards of efficacy.
3. NFLPA Former Players
Former NFL players bring a unique perspective and challenge when it comes to maintaining cognitive and physical health post-career. Many have experienced CTE or other injuries, making them ideal participants for testing InTheZone Focused and InTheZone Passion. We believe the results from this group will offer critical insights, demonstrating the effectiveness of our products for high-performing individuals and providing a real-world basis for anyone interested in taking their health to the next level.
Get In The Zone Today
We encourage everyone to visit InTheZoneLabs.com to explore these revolutionary products now available for purchase. Your feedback is invaluable as we continue to refine and expand the InTheZone Labs product line, so please don't hesitate to share your experience with us.
The Bioceutical Market Opportunity
The nutraceutical and bioceutical markets are projected to exceed
Stay tuned for more exciting updates from Nitches and InTheZone Labs, and be sure to check out our website to join us on this journey toward elevated health and performance.
Media Contact:
John Morgan
CEO
info@nitchescorp.com
About Nitches, Inc.
Nitches, Inc. (OTC: NICH) is a forward-thinking company dedicated to developing lifestyle and wellness products that deliver real, measurable results. Our InTheZone Labs division is at the forefront of bioceutical innovation, committed to creating premium supplements that help people unlock their full potential.
FDA Disclosure: These statements have not been evaluated by the Food and Drug Administration. The products mentioned are not intended to diagnose, treat, cure, or prevent any disease. All products are manufactured in FDA-audited facilities in compliance with Good Manufacturing Practices (GMP).
Forward-Looking Statements:
This press release may contain forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. These forward-looking statements are based on current expectations, estimates, and projections about Nitches Corp's industry, management's beliefs, and certain assumptions made by management. Words such as "anticipates," "expects," "intends," "plans," "believes," "seeks," "estimates," and similar expressions are intended to identify forward-looking statements. These statements are not guarantees of future performance and are subject to certain risks, uncertainties, and assumptions that are difficult to predict. Therefore, actual results may differ materially from what is expressed or forecasted in such forward-looking statements. Except as required by law, Nitches Corp undertakes no obligation to update publicly any forward-looking statements, whether as a result of new information, future events, or otherwise.
SOURCE: Nitches, Inc.
View the original press release on accesswire.com
FAQ
What are the three flagship products announced by Nitches Inc (NICH) for InTheZone Labs?
Who are the key groups involved in Nitches Inc's (NICH) Phase One Testing for InTheZone Labs products?
What is the projected market size for nutraceuticals and bioceuticals that Nitches Inc (NICH) is targeting?
Where can customers purchase InTheZone Labs products from Nitches Inc (NICH)?
